Lacosamide 70771-1682-06
- Manufacturer
- Zydus Lifesciences Limited
- Dosage Form
- Injection
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CV
- Marketing Start
- June 29, 2022
- Listing Expires
- December 31, 2026
- Application
- ANDA209465
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lacosamide | 10 mg/mL |
Drug Class
Decreased Central Nervous System Disorganized Electrical Activity [PE]
Selected Package
70771-1682-06Selected10 VIAL in 1 CARTON (70771-1682-6) / 20 mL in 1 VIAL (70771-1682-1)